{"id":"https://openalex.org/W2623948240","doi":null,"title":"Drug resistance mutations and their influencing factors in the patients infected with HIV-1 through different routes after antiretroviral therapy","display_name":"Drug resistance mutations and their influencing factors in the patients infected with HIV-1 through different routes after antiretroviral therapy","publication_year":2015,"publication_date":"2015-01-07","ids":{"openalex":"https://openalex.org/W2623948240","mag":"2623948240"},"language":"en","primary_location":{"id":"mag:2623948240","doi":null,"is_oa":false,"landing_page_url":"https://plamj.org/index.php/plamj/article/view/1181/1175","pdf_url":null,"source":{"id":"https://openalex.org/S2739286045","display_name":"Jiefangjun yixue zazhi","issn_l":"0577-7402","issn":["0577-7402"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311953","host_organization_name":"Editorial Board of Medical Journal of Chinese People's Liberation Army","host_organization_lineage":["https://openalex.org/P4310311953"],"host_organization_lineage_names":["Editorial Board of Medical Journal of Chinese People's Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiefangjun yixue zazhi","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082266396","display_name":"Xinli Lu","orcid":"https://orcid.org/0000-0003-4613-2028","observed_orcids":["https://orcid.org/0000-0003-4613-2028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xinli Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4613-2028","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055767356","display_name":"Xian-jiang Kang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xian-jiang Kang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103077130","display_name":"Hongru Zhao","orcid":"https://orcid.org/0000-0001-5744-417X","observed_orcids":["https://orcid.org/0000-0001-5744-417X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongru Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112382559","display_name":"Cuiying Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cuiying Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104928020","display_name":"Wei Wang","orcid":"https://orcid.org/0000-0001-9208-7569","observed_orcids":["https://orcid.org/0000-0001-9208-7569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9208-7569","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030529106","display_name":"Guangyi Bai","orcid":"https://orcid.org/0009-0001-1039-3448","observed_orcids":["https://orcid.org/0009-0001-1039-3448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guang-yi Bai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100380402","display_name":"Yan Li","orcid":"https://orcid.org/0000-0002-9481-8086","observed_orcids":["https://orcid.org/0000-0002-9481-8086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9481-8086","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Suliang Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suliang Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30263576,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"7","first_page":"591","last_page":"594"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-drug-resistance-mutations","display_name":"HIV-1 drug resistance mutations","score":0.9559999704360962},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hiv-transmission-routes","display_name":"HIV transmission routes","score":0.8059999942779541},{"id":"https://openalex.org/keywords/mother-to-child-transmission","display_name":"mother-to-child transmission","score":0.9150000214576721},{"id":"https://openalex.org/keywords/sexual-transmission","display_name":"sexual transmission","score":0.8650000095367432},{"id":"https://openalex.org/keywords/blood-transmission","display_name":"blood transmission","score":0.5130000114440918},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.7990000247955322},{"id":"https://openalex.org/keywords/risk-factors-for-drug-resistance","display_name":"risk factors for drug resistance","score":0.7229999899864197},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.6290000081062317},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/hebei-province","display_name":"Hebei Province","score":0.7099999785423279},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.3610000014305115}],"concepts":[{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.840984046459198},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.7464569807052612},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.7355844974517822},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6205329298973083},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5279021859169006},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5243449807167053},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5104659795761108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5072631239891052},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5012812614440918},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.45772749185562134},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4523332118988037},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.45079663395881653},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4104804992675781},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.365250825881958},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3338219225406647},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2809077799320221},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27396100759506226},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.24349799752235413},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09060779213905334},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0782335102558136}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2623948240","doi":null,"is_oa":false,"landing_page_url":"https://plamj.org/index.php/plamj/article/view/1181/1175","pdf_url":null,"source":{"id":"https://openalex.org/S2739286045","display_name":"Jiefangjun yixue zazhi","issn_l":"0577-7402","issn":["0577-7402"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311953","host_organization_name":"Editorial Board of Medical Journal of Chinese People's Liberation Army","host_organization_lineage":["https://openalex.org/P4310311953"],"host_organization_lineage_names":["Editorial Board of Medical Journal of Chinese People's Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiefangjun yixue zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8700000047683716}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2371443548","https://openalex.org/W2389735465","https://openalex.org/W2377753736","https://openalex.org/W2909470624","https://openalex.org/W2366335648","https://openalex.org/W2582767837","https://openalex.org/W2365854083","https://openalex.org/W2525354561","https://openalex.org/W3030817651","https://openalex.org/W2239659920"],"abstract_inverted_index":{"Objective\u3000To":[0],"analyze":[1],"HIV-1":[2,14,45,207],"drug":[3,58,208,221,239],"resistance":[4,59,209],"mutations":[5,60],"and":[6,56,110,128,158,184,198,220,223,241],"relative":[7],"factors":[8,237],"in":[9,26,138,146,154,163,247,251],"the":[10,72,136,173,185,233,244,255],"patients":[11,34,120,174],"infected":[12,37,175],"with":[13,38],"through":[15,40,176],"different":[16,41],"routes":[17],"after":[18],"having":[19],"received":[20],"highly":[21],"active":[22],"anti-retroviral":[23],"therapy":[24],"(HAART)":[25],"Hebei":[27],"province.":[28],"Methods\u3000Plasma":[29],"samples":[30],"were":[31,36,61,81,167],"collected":[32],"from":[33,83],"who":[35],"HIV":[39,57],"routes.":[42,178],"Detection":[43],"of":[44,54,71,117,126,181,214,225,227,235],"RNA":[46],"pol":[47],"region":[48,157],"was":[49,74,121],"carried":[50],"out":[51],"by":[52],"detection":[53],"genotype,":[55],"analyzed.":[62],"Results\u3000Among":[63],"266":[64,77],"patients,":[65,78],"157":[66],"developed":[67],"mutation.":[68],"The":[69,114,179],"rate":[70,116],"drug-resistance":[73,79,115],"59.0%.":[75],"Among":[76],"rates":[80],"ranked":[82],"high":[84],"to":[85,206,231,242,253],"low":[86],"as":[87],"follows:":[88],"NVP":[89],"65.8%":[90],"(175/266),":[91],"3TC":[92],"41.7%":[93,96],"(111/266),":[94,97],"FTC":[95],"EFV":[98],"30.1%":[99],"(80/266),":[100],"DDI":[101],"5.6%":[102],"(15/266),":[103],"D4T":[104],"4.1%":[105],"(11/266),":[106],"AZT":[107],"3.0%":[108,112],"(8/266)":[109],"ABC":[111],"(8/266).":[113],"blood":[118],"infection":[119,193],"much":[122],"higher":[123],"than":[124],"that":[125,135,191],"sexual":[127],"mother-to-child":[129],"transmission":[130],"ones,":[131],"but":[132],"\u03c72-test":[133],"indicated":[134,190],"differences":[137],"main":[139],"mutation":[140,210],"sites":[141],"(Y181C,":[142],"K103N,":[143],"V108I,":[144],"K101E":[145],"NNRTIS":[147],"coding":[148,156,165],"region,":[149],"M184V/I,":[150],"M41L,":[151],"T215F,":[152],"T215Y":[153],"NRTIs":[155],"A71V/T,":[159],"L10I,":[160],"M46L,":[161],"Q58E":[162],"PIs":[164],"region)":[166],"not":[168],"statistically":[169],"significant":[170,204],"(P>0.05)":[171],"among":[172],"three":[177],"results":[180],"OR":[182],"value":[183],"95%":[186],"confidence":[187],"interval":[188],"(CI)":[189],"age,":[192],"routes,":[194],"CD4+":[195,215],"cell":[196,216],"count":[197],"initial":[199],"therapeutic":[200,245,256],"plan":[201,246],"had":[202],"a":[203],"relevance":[205],"(P<0.05).":[211],"Conclusion\u3000Timely":[212],"monitor":[213],"number,":[217],"viral":[218],"load":[219],"resistance,":[222,240],"evaluation":[224],"progression":[226],"AIDS,":[228],"are":[229],"essential":[230],"minimize":[232],"influence":[234],"related":[236],"on":[238],"renew":[243],"time":[248],"during":[249],"HAART":[250],"order":[252],"enhance":[254],"effects.\n\t\t\n\t\tDOI:":[257],"10.11855/j.issn.0577-7402.2015.07.16":[258]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-06-15T00:00:00"}